Abstract:The last decade has witnessed the growing development of optical imaging using near-infrared (NIR) light (wavelength range: 700–1700 nm) in a wide range of applications, from fundamental research of live biological and physiological processes to clinical applications such as disease screening and image-guide surgical interventions. The low-energy NIR light offers reduced tissue scattering, absorption as well as autofluorescence background compared to traditional wavelengths in the visible (400–700 nm) range, thus dramatically enhancing imaging resolution, signal-to-noise ratio, and penetration depth. This Research Topic calls for advances in new fluorescent probes, imaging instrumentation, analytical methods and their applications for improvement of diagnosis and therapy in this “tissue transparent window,” aiming to provide a timely update of this continuously evolving filed. Imaging and diagnosis agents are the cornerstone of preclinical applications. In their study, Tan et al. report lycosin-I peptide modified gold nanoclusters (LGNCs), which exhibit strong NIR fluorescence, for imaging of specific cancer cell nuclei. The lycosin-I peptide not only possesses highly efficient and selective intracellular translocation against several cancer cells, but also induces aggregation of gold nanoclusters to further enhance their brightness. After uptake by tumor cells, the LGNCs aggregates can be depolymerized into ultrasmall nanoclusters by the high level GSH in the tumor microenvironment, facilitating nuclear targeting translocation in cancer cells. Another study by Huang et al. reports a novel biomimetic nanoprobe for photoacoustic (PA) imaging of cervical carcinoma. This probe is constructed by coating indocyanine green (ICG)-loaded mesoporous silica nanoparticles with the cancer cell membrane, providing small particle size, excellent dispersion, large loading efficiency, good biocompatibility and homologous targeting ability to Hela cells in vitro. The biomimetic nanoprobe can specifically accumulate into tumor and display a superior PA imaging efficacy compared with free ICG, allowing for non-invasive deep tissue imaging of cervical carcinoma in vivo. Another article by Gu et al. focuses on a particular type of NIR fluorophores, semiconducting polymer nanoparticles (SPNs). SPNs are constructed by encapsulating hydrophobic semiconducting polymers (SPs) with amphiphilic copolymers, and have shown great promise for phototheranostics of cancer. The authors review recent advances of thiadiazoloquinoxaline (TQ)-based SPNs from their synthesis and hydrophilic functionalization to NIR-II (1,000–1,700 nm) fluorescence imagingguided cancer photothermal therapy (PTT). To enhance the PTT efficiency, they also discuss methods for constructing SPNs with capability of multimodal imaging. Current limitations are summarized at the end that hamper clinical applications of the SPNs, such as relatively large size and low tumor targeting ability. Edited and reviewed by: Gianni Ciofani, Italian Institute of Technology (IIT), Italy

NIR fluorescence imaging and treatment for cancer immunotherapy

Early Tumor Detection Afforded by in Vivo Imaging of Near-Infrared Ii Fluorescence

Molecular Imaging for Cancer Immunotherapy: Seeing is Believing

Innovative optical imaging strategies for monitoring immunotherapy in the tumor microenvironments

Recent Advances in Near-Infrared-II Fluorescence Imaging for Deep-Tissue Molecular Analysis and Cancer Diagnosis

Advanced NIR-II Fluorescence Imaging Technology for Precise Evaluation of Nanomedicine Delivery in Cancer Therapy

Recent advances in fluorescence imaging-guided photothermal therapy and photodynamic therapy for cancer: From near-infrared-I to near-infrared-II

Near-infrared-II Fluorescence Imaging for Tumor Diagnosis and Therapy

Optical Imaging-Guided Cancer Therapy with Fluorescent Nanoparticles

Near-infrared Fluorescent Probes in Cancer Imaging and Therapy: an Emerging Field

Fluorescent imaging for cancer therapy and cancer gene therapy

Fluorescence Imaging of Tumor Immune Contexture in Immune Checkpoint Blockade Therapy.

In Vivo Near‐infrared Fluorescence Imaging of Cancer with Nanoparticle‐based Probes

Phototheranostics for Multifunctional Treatment of Cancer with Fluorescence Imaging

Advanced NIR‐II Fluorescence Imaging Technology for In Vivo Precision Tumor Theranostics

Molecularly Near-Infrared Fluorescent Theranostics for in Vivo Tracking Tumor-Specific Chemotherapy

Promising Approach for Optimizing In Vivo Fluorescence Imaging in a Tumor Mouse Model: Precision in Cancer Research

Noninvasively real-time monitoring in-vivo immune cell and tumor cell interaction by NIR-II nanosensor

Applications of Nanotheranostic in the Second Near-Infrared Window in Bioimaging and Cancer Treatment

The role of interventional radiology and molecular imaging for near infrared photoimmunotherapy

Editorial: Precise Diagnosis and Therapy Using Near-Infrared Light